Agios Pharma (AGIO) Tops Q1 EPS by 23c

Agios Pharma (NASDAQ: AGIO) reported Q1 EPS of ($1.55), $0.23 better than the analyst estimate of ($1.78). Revenue for the quarter came in at $8.7 million versus the consensus estimate of $9.97 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• List of suppliers, parts, photos of iPhone 18 Pro are part of Tata Electronics data breach - Reuters
• Zim Integrated shares rise after Maersk upgrades guidance
• Kansas City Capital Downgrades Apogee Enterprises (APOG) to Perform